From the Division of Acute Care Surgery, Department of Surgery (N.W., K.K., H.R., C.B., R.L., M.A., M.J.M.); Department of Physiology and Biophysics (M.J.M.); and Department of Emergency Medicine (M.J.M.), School of Medicine, Virginia Commonwealth University, Richmond, Virginia.
J Trauma Acute Care Surg. 2019 Aug;87(2):322-330. doi: 10.1097/TA.0000000000002332.
Previous ex vivo studies have shown that polyethylene glycol-20,000 Da (PEG-20k), a novel synthetic polymer that is highly effective for resuscitation, has a hypocoagulable effect on human blood. This study's objective was to determine the in vivo effects of PEG-20k-based resuscitation solutions on coagulation and platelet function in a porcine model of hemorrhagic shock.
Anesthetized pigs underwent controlled hemorrhage until the lactate reached 7 mmol/L or 50% to 55% of their estimated blood volume was removed. A laparotomy was performed to simulate tissue injury. Low volume resuscitation (LVR) was given with fluorescein isothiocyanate-labeled 10% PEG-20k solution (100 mg/mL) or Lactated Ringers, both delivered at volumes equal to 10% of the estimated blood volume (n = 5). Thromboelastography was performed after surgery (baseline), after hemorrhage, and 15 minutes, 120 minutes, and 240 minutes postresuscitation. Hemoglobin was measured to determine changes in plasma volume. Plasma PEG-20k concentration was measured by indicator dilution.
Pigs given PEG-20k survived 2.6-fold longer than controls (p < 0.001) and had a significant increase in plasma volume demonstrated by the sustained drop in hemoglobin, relative to controls. Pigs resuscitated with LR died from hypotension an average of 90 minutes after resuscitation compared to the PEG-20k pigs, which all survived 240 minutes and were then euthanized with normal blood pressure and lactate. Administration of PEG-20k primarily decreased the thromboelastograph maximum amplitude, however this began to return toward baseline by 240 minutes. Peak plasma concentration of PEG-20k after LVR were 40% lower than predicted, based on simple dilution (5.7 mg/mL vs. 10 mg/mL) and the half-life was 59.6 minutes.
These data demonstrate that acute resuscitation with PEG-20k significantly improves tolerance to hypovolemia but also decreases platelet function in the coagulation cascade, which was due, in part, to its volume expanding effects.
先前的离体研究表明,聚乙二醇-20000 道尔顿(PEG-20k)是一种新型合成聚合物,对复苏非常有效,对人血有低凝血作用。本研究的目的是确定基于 PEG-20k 的复苏液在失血性休克猪模型中的体内对凝血和血小板功能的影响。
麻醉猪进行控制性出血,直到乳酸达到 7mmol/L 或去除其估计血容量的 50%至 55%。进行剖腹术模拟组织损伤。低容量复苏(LVR)用荧光素异硫氰酸酯标记的 10% PEG-20k 溶液(100mg/mL)或乳酸林格氏液进行,两者的体积均等于估计血容量的 10%(n=5)。手术后(基线)、出血后以及复苏后 15 分钟、120 分钟和 240 分钟进行血栓弹性描记术。测量血红蛋白以确定血浆容量的变化。通过指示剂稀释测量血浆 PEG-20k 浓度。
与对照组相比,给予 PEG-20k 的猪存活时间长 2.6 倍(p<0.001),并且通过血红蛋白的持续下降显示出显著的血浆容量增加,与对照组相比。用 LR 复苏的猪平均在复苏后 90 分钟因低血压死亡,而 PEG-20k 猪均存活 240 分钟,然后用正常血压和乳酸盐安乐死。PEG-20k 的给药主要降低血栓弹性描记图的最大幅度,但到 240 分钟时开始恢复到基线。LVR 后 PEG-20k 的峰值血浆浓度比简单稀释(5.7mg/mL 与 10mg/mL)预测值低 40%,半衰期为 59.6 分钟。
这些数据表明,PEG-20k 的急性复苏显著提高了对低血容量的耐受性,但也降低了凝血级联中的血小板功能,这部分归因于其扩容作用。